株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臓器チップ (Organ-On-Chip) の世界市場:将来展望

Global Organ-On-Chip Market - 2019-2026

発行 DataM Intelligence 商品コード 792803
出版日 ページ情報 英文 130-180 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
臓器チップ (Organ-On-Chip) の世界市場:将来展望 Global Organ-On-Chip Market - 2019-2026
出版日: 2019年02月01日 ページ情報: 英文 130-180 Pages
概要

当レポートでは、世界の臓器チップ (Organ-On-Chip:生体機能チップ) 市場について分析し、市場の基本構造および最新情勢、全体的な市場動向の見通し (今後9年間分)、モデル別・エンドユーザー別および地域別の詳細動向、主な市場促進・抑制要因、市場競争構造、主要企業のプロファイル・事業戦略などについて調査しております。

第1章 分析範囲・手法

第2章 エグゼクティブ・サマリー

第3章 産業分析

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 影響度の分析

第4章 世界の臓器チップ (Organ -on-Chip) 市場:セグメント別

  • モデル別
    • 肝臓チップモデル (Liver-On-Chip)
    • 肺チップモデル (Lung-On-Chip)
    • 心臓チップモデル (Heart-On-a-Chip)
    • 腎臓チップモデル (Kidney-On-a-Chip)
    • 腫瘍モデル
    • カスタム型/多臓器チップモデル (Multi-Organ-On-Chip)
    • その他
  • エンドユーザー別
    • 製薬企業
    • 研究機関
    • その他

第5章 世界の臓器チップ市場:地域別

  • 地域別の市場概況
  • 北米 (米国、メキシコ、カナダ)
  • 欧州 (ドイツ、英国、フランス、イタリア、スペインなど)
  • 南米 (ブラジル、アルゼンチンなど)
  • アジア太平洋地域 (中国、インド、日本、オーストラリアなど)
  • 他の国々 (RoW)

第6章 競争環境

  • 競争シナリオ
  • ヒートマップ分析
  • 製品間の相互比較

第7章 企業プロファイル

  • CN Innovations Holdings Limited
  • Emulate, Inc.
  • Axosim Technologies LLC
  • CN Bio Innovations
  • Kirkstall Limited
  • Insphero Ag
  • Mimetas B.V.
  • Nortis Inc.
  • Tissuse Gmbh
  • Organovo Holdings, Inc.
  • Hesperos Inc

第8章 注目すべき主な企業

第9章 新興企業

第10章 付録

目次

Global Organ-On-Chip Market Overview

Organ-on-chip is a multi-channel 3-D micro fluid cell culture ship which stimulates activities, mechanisms, physiological responses of entire organs. These micro devices are translucent, they provide a window to watch inner workings of human organs. This technology is being used to develop a whole pipeline of human organs-on-chip such as lung, gut, liver, heart, skin, bone marrow, pancreas, kidney and even a system that mimics the blood brain barrier. These organ-on-chip help pharmaceutical companies in replacing animal cells, comparison studies between humans and animals, the study of the toxicity of drugs and cosmetics, developing vaccines and drugs to counter bioterrorism threats, etc.,

The global organ-on-chip market was worth $XX billion in 2018 and is forecasted to reach $XX billion by 2026, at a CAGR of XX% during the forecast period.

Market Drivers:

The provision of research funds grants is considered as the key driver for the progress in the development of OOC devices and also positively impacts its market growth globally

In 2017, NCATS awarded a research grant of $2 million to Emulate, Inc., to use its human Brain-Chip model and develop a fully automated research platform, to conduct experiments on the International Space Station.

In 2017, In 2017, NCATS and its NIH collaborators funded an estimated $15 million in the fiscal year 2017 to fund 13 awards for the 'Tissue Chips for Disease Modeling and Efficacy Testing initiative.'

The surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global organ-on-chip market. Real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in functional tissues are some of the applications of organ-on-chip devices in the industry.

Restraints:

Major factors hindering the global organ-on-chip market are the high cost of devices because of the high manufacturing cost associated with complex manufacturing techniques.

Market Segmentation

Global organ-on-chip market is segmented by model and end users. Model type includes Liver-On-chip model, Lung-on-chip model, Heart-on-chip model, Kidney-on-chip model, Tumor models, Custom & Multi-organ-on-Chip models, and others, end users includes pharmaceutical companies, research organizations, and others

Rise in mortality rate due to an increase in the incidence of liver diseases such as hepatitis B, is expected to propel the demand for the liver-on-chip microfluidic model. Additionally, the surge in demand for liver-on-chip devices for drug screening is expected to fuel market growth.

Global Organ-on-chip Market - Geographical Analysis

The global organ-on-chip market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

North America dominate the global organ-on-chip due to a surge in adoption of organs-on-chips over 2D and 3D cell cultures. Furthermore, rise in demand for organ-on-chip (OOCs) in drug screening, especially in the U.S., the rise in R&D initiatives and increase in a number of key players of OOCs in North America are expected to fuel the growth of the market in the coming years.

On April 11, 2017, FDA announced a multi-year research and development agreement with a company called Emulate Inc. to test the company's "Organs-on-Chips" technology in laboratories at the agency's Center for Food Safety and Applied Nutrition.

Global Organ-On-Chip Market - Competitive Analysis

Collaborative partnerships among the key players for research and development of advanced technology in the field of organ-on-chip and new product launches are driving the global organ-on-chip market.

In May 2018, Emulate, Inc. has formed a collaborative partnership with AstraZeneca's Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization.

In May 2018, CN Bio Innovations globally launched an organ-on-a-chip device that allows scientists to test potential drugs on living human organ models.

In October 2017, InSphero AG and Charles River Laboratories International, Inc. announced a partnership for the development of 3D InSight™ PDX Microtissues and expansion of in vitro oncology services.

In September 2017, AxoSim Technologies received a USD 1.7 million grant to expand its research aimed at fixing issues in pharmaceutical development.

Major market players in the Organ-on-chip market are CN Innovations Holdings Limited, Emulate, Inc., Axosim Technologies LLC, CN Bio Innovations, Kirkstall Limited, Insphero Ag, Mimetas B.V., Nortis Inc., Tissuse Gmbh, Organovo Holdings, Inc., and Hesperos Inc.

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. GLOBAL ORGAN-ON-CHIP MARKET -SCOPE AND METHODOLOGY

  • 1.1. Research Methodology
  • 1.2. The Scope of the market

2. GLOBAL ORGAN-ON-CHIP MARKET-EXECUTIVE SUMMARY

3. INDUSTRY ANALYSIS

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunity
  • 3.4. Impact Analysis

4. GLOBAL ORGAN-ON-CHIP MARKET SEGMENTATION

  • 4.1. BY MODEL
    • 4.1.1. Liver-On-Chip Model
    • 4.1.2. Lung-On-Chip Model
    • 4.1.3. Heart-On-Chip Model
    • 4.1.4. Kidney-On-Chip Model
    • 4.1.5. Tumor Models
    • 4.1.6. Custom & Multi-Organ-On-Chip Models
    • 4.1.7. Other
  • 4.2. BY END USERS
    • 4.2.1. Pharmaceutical Companies
    • 4.2.2. Research Organizations
    • 4.2.3. Others

5. GLOBAL ORGAN-ON-CHIP MARKET - BY GEOGRAPHY

  • 5.1. Geographic Overview
  • 5.2. North America
    • 5.2.1. The U.S.
    • 5.2.2. Mexico
    • 5.2.3. Canada
  • 5.3. Europe
    • 5.3.1. Germany
    • 5.3.2. The U.K.
    • 5.3.3. France
    • 5.3.4. Italy
    • 5.3.5. Spain
    • 5.3.6. Rest of Europe
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. Asia Pacific
    • 5.5.1. China
    • 5.5.2. India
    • 5.5.3. Japan
    • 5.5.4. Australia
    • 5.5.5. Rest of Asia Pacific
  • 5.6. Rest of World

6. COMPETITIVE LANDSCAPE

  • 6.1. Competitive Scenario
  • 6.2. Heat Map Analysis
  • 6.3. Product Benchmarking

7. COMPANY PROFILES

  • 7.1. CN Innovations Holdings Limited
  • 7.2. Emulate, Inc.
  • 7.3. Axosim Technologies LLC
  • 7.4. CN Bio Innovations
  • 7.5. Kirkstall Limited
  • 7.6. Insphero Ag
  • 7.7. Mimetas B.V.
  • 7.8. Nortis Inc.
  • 7.9. Tissuse Gmbh
  • 7.10. Organovo Holdings, Inc.
  • 7.11. Hesperos Inc

8. Key companies to watch

9. Emerging Companies

10. APPENDIX

  • 10.1. Sources
  • 10.2. List of Tables
  • 10.3. Expert Panel Validation
  • 10.4. Disclaimer
  • 10.5. Contact Us
Back to Top